The problematic history of randomised controlled trials Part 3: Mainland,Hill and the future of RCTs

Mainland D. Problems of chance in clinical work. BMJ 1936; 2: 221–224.

Fisher RA. Statistical Methods for Research Workers. Edinburgh: Oliver & Boyd, 1925.

Mainland D. The rise of experimental statistics and the problems of a medical statistician. Yale J Biol Med 1954; 27: 1–10.

Altman DG. Donald Mainland: anatomist, educator, thinker, medical statistician, trialist, rheumatologist. J R Soc Med 2020; 113: 28–38. See https://www.jameslindlibrary.org/articles/donald-mainland-anatomist-educator-thinker-medical-statistician-trialist-rheumatologist/ (accessed 17 December 2025)

Hill AB . Principles of Medical Statistics. 1st ed. London: Lancet. See https://www.jameslindlibrary.org/hill-ab-1937b/ (1937) (accessed 17 December 2025)

Medical Research Council. Streptomycin treatment of pulmonary tuberculosis. BMJ 1948; 2: 769–782. See https://www.jameslindlibrary.org/medical-research-council-1948b/ (accessed 17 December 2025)

Mainland D. Statistical methods in medical research. I. Qualitative statistics (enumeration data). Can J Res 1948; 26: 1–166. See https://www.jameslindlibrary.org/mainland-d-1948/ (accessed 17 December 2025)

Mainland D . Elementary Medical Statistics. Philadelphia: WB Saunders. See https://www.jameslindlibrary.org/mainland-d-1952/ (accessed 17 December 2025) (1952).

Mainland D . Elementary medical statistics. 2nd ed. Philadelphia: WB Saunders. See https://www.jameslindlibrary.org/mainland-d-1963-2/ (last checked 17 December 2025) (1963).

Mainland D. The planning of investigations. Methods Med Res 1954; 6: 138–145.

Mainland D . The Treatment of Clinical and Laboratory Data: An Introduction to Statistical Ideas and Methods for Medical and Dental Workers. Edinburgh: Oliver and Boyd. See https://www.jameslindlibrary.org/mainland-d-1938/ (accessed 17 December 2025) (1938).

Wasserstein RL Lazar NA. The ASA statement on p-values: context, process, and purpose. Am Stat 2016; 70: 129–133.

Feinstein AR . Clinical biostatistics. 1. A new name – and some other changes of the guard. Clin Pharmacol Ther 1970; 11: 135–148.

Schoolman HM. The clinician and the statistician. Stat Med 1982; 1: 311–316.

Farewell V Johnson T. Woods and Russell, Hill, and the emergence of medical statistics. Stat Med 2010; 29: 1459–1476. See https://www.jameslindlibrary.org/farewell-v-johnson-t-2010/ (accessed 17 December 2025)

Armitage P. Obituary: Sir Austin Bradford Hill, 1897–1991. J R Stat Soc Ser A 1991; 154: 482–484.

Rao CR. RA Fisher: The founder of modern statistics. Stat Sci 1992; 7: 34–48.

Neuhauser D Provost SM Provost LP. It is time to reconsider factorial designs: how Bradford Hill and RA Fisher shaped the standard of clinical evidence. Qual Manag Health Care 2020; 29: 109–122.

Chalmers I. Why transition from alternation to randomisation in clinical trials was made. BMJ 1999; 319: 1372.

Chalmers I . Statistical theory was not the reason that randomization was used in the British Medical Research Council’s Clinical Trial of streptomycin for pulmonary tuberculosis. In: Jorland G Weisz G Opinel A (eds) Body Counts: Medical Quantification in Historical and Sociological Perspective. Montreal: McGill-Queen’s Press, pp. 309–334.

Chalmers I. UK Medical Research Council and multicentre clinical trials: from a damning report to international recognition. J R Soc Med 2013; 106: 498–509. See https://www.jameslindlibrary.org/articles/uk-medical-research-council-and-multicentre-clinical-trials-from-a-damning-report-to-international-recognition/ (accessed 17 December 2025)

Rosenberger WF Uschner D Wang Y. Randomization: The forgotten component of the randomized clinical trial. Stat Med 2019; 38: 1–12.

Rosenberger WF Lachin JM. Randomization in Clinical Trials: Theory and Practice. Hoboken: John Wiley, 2015.

Rosenberger WF. From Fisher to CARA: the evolution of randomization and randomization-based inference. J R Stat Soc Ser A Stat Soc 2026; 189: 497–511.

Peto R. Clinical trial methodology. Biomed 28 (special issue) 1978; 24–36. See https://www.jameslindlibrary.org/peto-r-1978/ (accessed 17 December 2025)

Bodmer W. RA Fisher, statistician and geneticist extraordinary: a personal view. Int J Epidemiol 2003; 32: 938–942.

White IR Szubert AJ Choodari-Oskooei B , et al. When should factorial designs be used for late-phase randomised controlled trials? Clin Trials 2024; 21: 162–170.

Glasziou PP Tikkinen KA. The RECOVERY trial platform: a milestone in the development and execution of treatment evaluation during an epidemic. J R Soc Med 2021; 114: 443–446. See https://www.jameslindlibrary.org/articles/the-recovery-trial-platform-a-milestone-in-the-development-and-execution-of-treatment-evaluation-during-an-epidemic/ (accessed 17 December 2025)

NHS News COVID treatment developed in the NHS saves a million lives (press release 23 March 2021). See https://www.england.nhs.uk/2021/03/covid-treatment-developed-in-the-nhs-saves-a-million-lives/ (accessed 17 December 2025).

Ramagopalan SV Simpson A Sammon C. Can real-world data really replace randomised clinical trials? BMC Med 2020; 18: 13.

Yaacoub S Porcher R Pellat A , et al. Characteristics of non-randomised studies of drug treatments: cross sectional study. BMJ Med 2024; 3: e000932.

Mayo CS Matuszak MM Schipper MJ , et al. Big data in designing clinical trials: opportunities and challenges. Front Oncol 2017; 7: 187.

Meng X. Statistical paradises and paradoxes in big data (I): law of large populations, big data paradox, and the 2016 US presidential election. Ann Appl Stat 2018; 12: 685–726.

Bradley VC Kuriwaki S Isakov M , et al. (2021). Unrepresentative big surveys significantly overestimated US vaccine uptake. Nature 2021; 600: 695–700. See https://www.jameslindlibrary.org/bradley-vc-kuriwaki-s-isakov-m-sejdinovic-d-meng-x-flaxman-s-2021/ (accessed 17 December 2025)

Schoeler T Speed D Porcu E , et al. Participation bias in the UK Biobank distorts genetic associations and downstream analyses. Nat Human Behav 2023; 7: 1216–1227. See https://www.jameslindlibrary.org/schoeler-t-speed-d-porcu-e-pirastu-n-pingault-jb-kutalik-z-2023/ (accessed 17 December 2025).

Msaouel P. The curious rise of randomised non-comparative trials. Significance 2025; 22: 40–44.